Literature DB >> 32269054

Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules.

Maxime Meylan1,2, Florent Petitprez1,2, Laetitia Lacroix1, Luca Di Tommaso3,4, Massimo Roncalli3,4, Antoine Bougoüin1, Alexis Laurent5, Giuliana Amaddeo6,7, Daniele Sommacale5,7, Hélène Regnault6, Jonathan Derman8, Cécile Charpy8, Fouad Lafdil7, Jean-Michel Pawlotsky7,9, Catherine Sautès-Fridman1, Wolf H Fridman1, Julien Calderaro10,7,8.   

Abstract

PURPOSE: The impact of tertiary lymphoid structures (TLS) in hepatocellular carcinoma (HCC) progression is being extensively investigated. However, their presence during the early steps of human liver carcinogenesis remains unknown. We thus aimed to determine whether TLS are induced in preneoplastic/early hepatic lesions (EHL), and whether they are associated with a particular immune profile. EXPERIMENTAL
DESIGN: A series of 127 EHLs (low/high-grade dysplastic nodules, early HCC, and small and progressed HCC) was included in the study. TLSs were investigated by pathologic reviewing. Densities of immune cells were assessed using IHC. A subset of lesions was microdissected and gene expression profiling was performed with a custom NanoString panel.
RESULTS: Compared with surrounding cirrhotic nodules, EHL of all stages displayed increased densities of T cells, B cells, and dendritic cells. Immature TLSs were identified in 24% of EHL. Gene expression profiling identified a subset of EHL with elevated mRNA levels of various cytokines involved in immune cells' recruitment and TLS induction. This subgroup of EHL also showed overexpression of genes related to T- and B-cells' activation and antigen presentation, as well as those related to immunosuppression and immune exhaustion.
CONCLUSIONS: Local immune activation occurs in the very early steps of liver carcinogenesis; however, it may not be fully efficient and paradoxically favor immune evasion and progression to full-blown HCC. These results have implications for the development of anti-HCC chemopreventive strategies in cirrhotic patients. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 32269054     DOI: 10.1158/1078-0432.CCR-19-2929

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  14 in total

Review 1.  B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome.

Authors:  Wolf H Fridman; Maxime Meylan; Florent Petitprez; Cheng-Ming Sun; Antoine Italiano; Catherine Sautès-Fridman
Journal:  Nat Rev Clin Oncol       Date:  2022-04-01       Impact factor: 65.011

2.  CD20+CD22+ADAM28+ B Cells in Tertiary Lymphoid Structures Promote Immunotherapy Response.

Authors:  Zhenghao Wu; Junjie Zhou; Yunxiao Xiao; Jie Ming; Jing Zhou; Fang Dong; Xiaoqi Zhou; Zhuoshuo Xu; Xiangwang Zhao; Ping Lei; Tao Huang
Journal:  Front Immunol       Date:  2022-05-11       Impact factor: 8.786

Review 3.  Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications.

Authors:  Terence Kin-Wah Lee; Xin-Yuan Guan; Stephanie Ma
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-09-09       Impact factor: 46.802

Review 4.  Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.

Authors:  Jacquelot N; Tellier J; Nutt Sl; Belz Gt
Journal:  Oncoimmunology       Date:  2021-03-29       Impact factor: 8.110

5.  B cells and cancer: To B or not to B?

Authors:  Wolf Herman Fridman; Florent Petitprez; Maxime Meylan; Tom Wei-Wu Chen; Cheng-Ming Sun; Lubka T Roumenina; Catherine Sautès-Fridman
Journal:  J Exp Med       Date:  2021-01-04       Impact factor: 14.307

6.  Editorial: Tertiary Lymphoid Structures: From Basic Biology to Translational Impact in Cancer.

Authors:  Catherine Sautès-Fridman; Anna Dimberg; Vivek Verma
Journal:  Front Immunol       Date:  2022-03-16       Impact factor: 8.786

Review 7.  Mechanisms of induction of regulatory B cells in the tumour microenvironment and their contribution to immunosuppression and pro-tumour responses.

Authors:  Fabian Flores-Borja; Paul Blair
Journal:  Clin Exp Immunol       Date:  2022-07-22       Impact factor: 5.732

Review 8.  Immune Crosstalk Between Lymph Nodes and Breast Carcinomas, With a Focus on B Cells.

Authors:  Elena Alberts; Isobelle Wall; Dinis Pedro Calado; Anita Grigoriadis
Journal:  Front Mol Biosci       Date:  2021-05-28

9.  Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma.

Authors:  Laia Bassaganyas; Roser Pinyol; Roger Esteban-Fabró; Laura Torrens; Sara Torrecilla; Catherine E Willoughby; Sebastià Franch-Expósito; Maria Vila-Casadesús; Itziar Salaverria; Robert Montal; Vincenzo Mazzaferro; Jordi Camps; Daniela Sia; Josep M Llovet
Journal:  Clin Cancer Res       Date:  2020-09-01       Impact factor: 12.531

Review 10.  Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation.

Authors:  Charlotte Domblides; Juliette Rochefort; Clémence Riffard; Marylou Panouillot; Géraldine Lescaille; Jean-Luc Teillaud; Véronique Mateo; Marie-Caroline Dieu-Nosjean
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.